Therapeutic Device Reduces the Prostate Volume in Men with Benign Prostatic Hyperplasia, Easing Lower Urinary Tract Symptoms, Naturally

Background: Benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate gland, is the most common benign tumour found in men. BPH is responsible for the development of lower urinary tract symptoms (LUTS). However, there have been contradictory reports about the correlation between the prostate volume (PV) and development of BPH symptoms. The aim of this study was to find if there is a link between PV and LUTS. Methods: Before and after 6 months men older than 55 with LUTS and prostatic enlargement had the following tests twice: the International Prostate Symptom Score (IPSS), ultrasound measurement of PV and uroflowmetry maximum flow rate (Qmax). The effectiveness of Thermobalancing therapy enabled by therapeutic device was thoroughly investigated in 124 men with BPH and PV < 60 mL. We also present here case studies of 2 men with PV > 60 mL who used the device for 7 months. Results: The outcomes of investigated tests in 124 men with the PV <60 mL verified decrease of IPSS (P <0.001)and improvement of quality of life (QoL) (P <0.001),reduction of PV (P <0.001) and increase of Qmax(P <0.001).Furthermore, the prostate volume in men with PV > 60 reduced significantly after wearing the device for 7 months but numbers of PV were still abnormal. Conclusions: The observed positive changes in PV and BPH symptoms under Thermobalancing therapy demonstrate that there is tight correlation between PV and IPSS. Men with PV > 60 require more time for therapy. As therapeutic device is side effects free and safe it can be used when enlarged prostate is diagnosed without waiting of LUTS to progress, i.e. in the watchful waiting stage.